The new cleanroom at our global headquarters in Salt Lake City, Utah, was designed for today's rigorous contamination control expectations, driven by EU GMP Annex 1. Learn More
Blog Post 2 – MIND THE LABEL: rapid impurity identification through in-house intelligence 2 min reading time Even subtle changes in secondary packaging can introduce unexpected impurities into drug products—posing risks to quality and patient safety. In this first case...
Blogpost 1 – An unexpected impurity in my drug product, what now? 6-7 min reading time Welcome to the first article in a series of blog posts on impurities in drug products. These blog posts will focus on different situations...
Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in...
Getting a fever, is something that all of us have experienced. However, when we use medicines or medical devices, we need them to improve our health—they should not cause a fever. One of the culprits of fevers is the presence...
CLEVELAND, OH. – Oct. 31, 2017 – Sterigenics International LLC announced today that it has acquired Toxikon Europe N.V., the European division of Toxikon Corporation, a Bedford, Mass.-based preclinical contract research organization. Terms of the deal were not disclosed.
